Keywords: ÎΨ; Mitochondrial membrane potential; Aβ; Amyloid beta; AD; Alzheimer's disease; AMPA; α-amino-3-hydroxy-5-methylisoxazole-4-propionate; ApoE/D; Apolipoproteins E/D; BBB; Blood brain barrier; GSH; glutathione; HD; Huntington's disease; H2O2; hydrogen
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: α-Syn; alpha-synuclein; CBE; conduritol-B-epoxide; CCCP; carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone; CS; citrate synthase; Cx I; mitochondrial respiratory chain complex I; DA; dopaminergic; DIV; day in vitro; DMSO; dimethyl sulfoxide; EDTA; eth
Keywords: CI; cerebral ischemia; PD; Parkinson's disease; HD; Huntington's disease; SN; substancia nigra; DA; dopamine; GABA; gamma-aminobutyric acid; MSN; medium spiny neuron; CNS; central nervous system; NSC; neural stem cells; ES; embryonic stem; MSC; mesenchyma
The inhibitory effects of eighteen front-line antibiotics on the substrate uptake mediated by human Organic anion/cation transporters, Organic anion transporting polypeptides and Oligopeptide transporters in in vitro models
Keywords: SLCs; Solute Carrier transporters; CCK-8; Cholecystokinin octapeptide; ES; estrone-3-sulfate; PAH; 4-aminohippuric acid; MPPÂ +; Â methyl-4-phenylpyridinium acetate; Gly-Sar; glycyl-sarcosine; MTX; methotrexate; Front-line antibiotics; Organic anion/catio
Methyl-4-phenylpyridinium (MPPÂ +) differentially affects monoamine release and re-uptake in murine embryonic stem cell-derived dopaminergic and serotonergic neurons
Keywords: Dopamine transporter; Serotonin transporter; MPPÂ +; Â Transporter trafficking; Parkinson's disease; Stem cells;
Research PaperCapsaicin protects cortical neurons against ischemia/reperfusion injury via down-regulating NMDA receptors
Keywords: BBB; blood-brain barrier; DIV; days in vitro; DMSO; dimethyl sulphoxide; DRG; dorsal root ganglion; KO; knock-out; LDH; lactate dehydrogenase; MCAO; middle cerebral artery occlusion; MPPÂ +; Â 1-methyl-4-phenylpyridinium; NMDA; N-methyl-d-aspartic acid; P
HSPA5 Gene encoding Hsp70 chaperone BiP in the endoplasmic reticulum
Keywords: aa; amino acid; ATF6; activating transcription factor 6; BIK; BCL2-interacting killer; BiP; binding immunoglobulin protein; CD86; cluster of differentiation 86; CHOP; CCAAT-enhancer-binding protein homologous protein; Derlin-1; degradation in ER protein 1
Increased neurotrophic factor levels in ventral mesencephalic cultures do not explain the protective effect of osteopontin and the synthetic 15-mer RGD domain against MPPÂ + toxicity
Keywords: 6-OHDA; 6-hydroxydopamine; BDNF; brain-derived neurotrophic factor; ED-1; ectodermal dysplasia 1; GDNF; glial-derived neurotrophic factor; GFAP; glial fibrillary acidic protein; MPPÂ +; 1-methyl-4-phenylpyridinium; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahyd
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism
Keywords: Parkinson's disease; Captopril; Angiotensin converting enzyme; Dopamine neurodegeneration; Mice; Rats; MPTP; MPPÂ +; Microglia; Osmotic minipump;
Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
Keywords: PD; Parkinson's disease; MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPPÂ +; 1-methyl-4-phenyl pyridium; MAO; monoamine oxidase; DAT; dopamine transporter; CCR; C-C chemokine receptor; MIP; macrophage inflammatory protein; KO; knockout; WT; wild